Principles of Management of Women with Hirsutism: A Dermatologist’s Perspective

    January 2020 in “ Przegla̧d dermatologiczny ”
    Dominik Mikiel, Barbara Głowińska-Olszewska, Adriana Polańska, Zygmunt Adamski, Ryszard Żaba, Aleksandra Dańczak‐Pazdrowska
    Image of study
    TLDR The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.
    The document from 2020, "Principles of management of women with hirsutism – a dermatologist’s perspective", discussed hirsutism, a condition characterized by excessive growth of terminal hair in androgen-sensitive areas, affecting 5–15% of women. The condition is primarily caused by ovarian or adrenal hyperandrogenism, but can also be idiopathic, drug-induced, or caused by other endocrinopathies. The severity of hirsutism can be evaluated using a modified Ferriman-Gallwey visual scoring scale. The paper presented various treatment options, including hair removal using lasers or electrolysis, combined oral contraception, antiandrogens, and topical eflornithine. The document provided a clinical scheme for diagnosing and managing hirsutism from a dermatological perspective.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 24 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    3 / 3 results